Back

M.J.M. (Mick) van Eijs MSc

M.J.M. (Mick) van Eijs MSc

PHD Candidate - Medical
M.J.M. (Mick) van Eijs MSc
  • Dept of Medical Oncology

Research Programs

Cancer

Biography

Biography

Current position:

PhD candidate onco-immunology, UNICIT study: UNICIT - UMC Utrecht

 

Education:

2020 Medicine (MSc), Utrecht University

2018 Health Economics, Policy and Law (MSc), Erasmus University Rotterdam

2016 Medicine (BSc), Utrecht University

 

Research Output (6)

Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis

van Eijs Mick J.M., ter Linde José J.M., Baars Matthijs J.D., Amini Mojtaba, Laclé Miangela M., Brand Eelco C., Delemarre Eveline M., Drylewicz Julia, Nierkens Stefan, Verheijden Rik J., Oldenburg Bas, Vercoulen Yvonne, Suijkerbuijk Karijn P.M., van Wijk Femke 20 Oct 2023, In: iScience. 26

Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition

van Eijs Mick J M, Verheijden Rik J, van der Wees Stefanie A, Nierkens Stefan, van Lindert Anne S R, Suijkerbuijk Karijn P M, van Wijk Femke, 4 Oct 2023, In: Cancer Immunology, Immunotherapy. 72 , p. 4049-4064 16 p.

Immunosuppression for immune-related adverse events during checkpoint inhibition:an intricate balance

Verheijden Rik J, van Eijs Mick J M, May Anne M, van Wijk Femke, Suijkerbuijk Karijn P M 12 May 2023, In: NPJ precision oncology. 7

Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies

Van Not Olivier J, van den Eertwegh Alfons J M, Haanen John B, van Rijn Rozemarijn S, Aarts Maureen J B, van den Berkmortel Franchette W P J, Blank Christian U, Boers-Sonderen Marye J, van Eijs Mick J M, de Groot Jan-Willem B, Hospers Geke A P, Kapiteijn Ellen, de Meza Melissa, Piersma Djura, Stevense-den Boer Marion, van der Veldt Astrid A M, Vreugdenhil Gerard, Wouters Michel W J M, Suijkerbuijk Karijn P M, Blokx Willeke A M 16 Mar 2023, In: European Journal of Cancer. 186 , p. 27-37 11 p.

Hematologic malignancies following immune checkpoint inhibition for solid tumors

van Eijs Mick J.M., van der Wagen Lotte E., Mous Rogier, Leguit Roos J., van de Corput Lisette, van Lindert Anne S.R., Suelmann Britt B.M., Kamphuis Anna M., Nierkens Stefan, Suijkerbuijk Karijn P.M. 13 Jun 2022, In: Cancer Immunology, Immunotherapy. 72 , p. 249-255 7 p.

Checkpoint inhibition:protecting against or predisposing for second primary tumors?

Suijkerbuijk K P M, May A M, van Eijs M J M 29 Mar 2021, In: Annals of oncology : official journal of the European Society for Medical Oncology. 32 , p. 935-935 1 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not